Protein-Binding High-Performance Frontal Analysis of (R)- and (S)-warfarin on HSA with and without Phenylbutazone
- 1 January 1997
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (1), 120-125
- https://doi.org/10.1021/js9600134
Abstract
Applicability of high-performance frontal analysis (HPFA) to the stereoselective study of drug-drug interaction upon plasma protein binding has been investigated. Racemic warfarin and phenylbutazone were used as model drugs. An on-line HPFA/HPLC system consisting of a HPFA column (diol-silica column), an extraction column, and a chiral separation column was developed, and human serum albumin solution containing racemic warfarin and/or phenylbutazone was injected directly to the HPFA column. When the injection volume was large enough, the binding equilibrium in the sample solution was reproduced in the column, and consequently a plateau region appeared on the chromatogram. This plateau region contains unbound drug(s). A given volume of eluent in the plateau part was transferred into the extraction column by column-switching. The concentrated drug(s) was then transferred to the chiral separation column to determine the unbound concentrations of the enantiomers and/or the competitor. The results agreed with those obtained by a conventional ultrafiltration-HPLC method. The influence of phenylbutazone upon the protein binding of warfarin is enantioselective. In warfarin and human serum albumin mixed solution, the unbound concentration of (R)-warfarin was 1.22 times higher than that of the S-isomer. By addition of phenylbutazone, the unbound concentration of (S)-warfarin increased more than that of (R)-warfarin, resulting in the reversed enantioselectivity, i.e., the unbound concentration of (S)-warfarin became 1.19 times larger than that of (R)-warfarin. The present method was also applicable to human plasma samples.Keywords
This publication has 34 references indexed in Scilit:
- High-Performance Frontal Analysis/High-Performance Liquid Chromatographic System for the Enantioselective Determination of Unbound Fenoprofen Concentration in Protein Binding EquilibriumJournal of Liquid Chromatography, 1993
- Warfarin metabolites: Stereochemical aspects of protein binding and displacement by phenylbutazoneChirality, 1993
- Enantiomer specific pharmacokineticsPharmacology & Therapeutics, 1990
- Simultaneous determination of the free and total carbamazepine concentrations in human plasma by high-performance frontal analysis using an internal-surface reversed-phase silica support.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Binding of Nonsteroidal Anti-Inflammatory Agents and Their Effect on Binding of Racemic Warfarin and Its Enantiomers to Human Serum AlbuminJournal of Pharmaceutical Sciences, 1989
- Determination of free drug in protein binding equilibrium by high-performance frontal analysis using internal-surface reversed-phase silica support.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Pharmacokinetic Consequences of Drug Displacement from Blood and Tissue ProteinsClinical Pharmacokinetics, 1984
- Some fluorescent investigations of the interaction between the enantiomers of warfarin and human serum albuminInternational Journal of Pharmaceutics, 1979
- Protein binding of warfarin enantiomers in serum of humans and ratsJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Binding of Drugs by Albumin Plasma ProteinJournal of Pharmaceutical Sciences, 1977